TIFFANY KIRK: Open Payments
NPI 1619491024 · MARSHFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 29 payments from 10 companies in 2025. Trend: 2023 $1,191 · 2024 $798 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $177 |
| Otsuka America Pharmaceutical, Inc. | 4 | $173 |
| ABBVIE INC. | 5 | $91 |
| PFIZER INC. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: REXULTI, AIRSUPRA, VRAYLAR, NURTEC ODT, FARXIGA, COBENFY, Veozah, BREZTRI.
Industry payments across MO — which companies pay providers there.
